Table 4 The association between the insulin response dietary and lifestyle indices and incidence of insulin related disorders after excluding the diabetic patients in the baseline of study

Hyperinsulinemia

 Median score

1.04

1.28

1.55

0.02

0.14

0.37

 Case/Total

34/273

59/264

68/258

64/261

41/268

57/272

 Model 1^a

1.00 (Ref.)

2.14 (1.33–3.45)

2.66 (1.66–4.28)

1.00 (Ref.)

0.55 (0.35–0.88)

0.72 (0.47–1.12)

 Model 2^b

1.00 (Ref.)

2.15 (1.33–3.46)

2.62 (1.62–4.22)

1.00 (Ref.)

0.56 (0.35–0.89)

0.73 (0.45–1.17)

 Model 3^c

1.00 (Ref.)

2.15 (1.33–3.46)

2.61 (1.62–4.22)

1.00 (Ref.)

0.56 (0.35–0.89)

0.73 (0.45–1.16)

Insulin resistance

 Median score

1.03

1.27

1.51

0.02

0.15

0.40

 Case/Total

40/236

74/234

89/230

66/232

64/237

73/236

 Model 1^a

1.00 (Ref.)

2.26 (1.45–3.52)

2.95 (1.90–4.58)

1.00 (Ref.)

1.03 (0.68–1.57)

1.22 (0.80–1.84)

 Model 2^b

1.00 (Ref.)

2.25 (1.44–3.51)

2.87 (1.84–4.47)

1.00 (Ref.)

0.97 (0.63–1.50)

1.10 (0.70–1.74)

 Model 3^c

1.00 (Ref.)

2.24 (1.43–3.50)

2.83 (1.82–4.26)

1.00 (Ref.)

0.96 (0.62–1.48)

1.10 (0.70–1.73)

β-cell dysfunction

 Median score

1.09

1.35

1.66

0.02

0.15

0.39

 Case/Total

107/314

68/314

43/304

89/309

64/314

68/317

 Model 1^a

1.00 (Ref.)

0.51 (0.35–0.73)

0.29 (0.19–0.44)

1.00 (Ref.)

0.60 (0.41–0.88)

0.76 (0.52–1.11)

 Model 2^b

1.00 (Ref.)

0.51 (0.35–0.74)

0.30 (0.19–0.45)

1.00 (Ref.)

0.64 (0.43–0.96)

0.84 (0.55–1.27)

 Model 3^c

1.00 (Ref.)

0.52 (0.36–0.76)

0.30 (0.19–0.45)

1.00 (Ref.)

0.66 (0.44–0.98)

0.84 (0.55–1.27)

Insulin insensitivity

 Median score

1.03

1.27

1.51

0.02

0.15

0.40

 Case/Total

40/234

73/233

89/231

66/231

64/237

72/235

 Model 1^a

1.00 (Ref.)

2.23 (1.43–3.48)

2.89 (1.86–4.50)

1.00 (Ref.)

1.01 (0.67–1.54)

1.17 (0.77–1.78)

 Model 2^b

1.00 (Ref.)

2.23 (1.43–3.49)

2.82 (1.81–4.39)

1.00 (Ref.)

0.95 (0.61–1.46)

1.04 (0.66–1.63)

 Model 3^c

1.00 (Ref.)

2.31 (1.42–3.48)

2.78 (1.78–4.34)

1.00 (Ref.)

0.93 (0.60–1.44)

1.03 (0.65–1.62)